Evans DG, Houston S, Donnai D, Neary W, Blair V, NewtonV, Harris R. A clinical study of type 2 neurofibromatosis. Q J Med. 1992;84:603–18.

CAS  PubMed  Google Scholar 

Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16.

Article  PubMed  PubMed Central  Google Scholar 

Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. Birth incidence and prevalence of tumour prone syndromes: estimates from a UK genetic family register service. Am J Med Genet. 2010;152A:327–32.

Article  CAS  PubMed  Google Scholar 

Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, Samii M, Wais R, Pulst SM. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery. 1996;38:880–5.

Article  CAS  PubMed  Google Scholar 

Andern-Holmes S, Fisher G, North K. Neurofibromatosis type 2. J Child Neurol. 2017;32:9–22.

Article  Google Scholar 

Anand G, Vasallo G, Spanou M, Thomas S, Pike M, Kariyawasam DS, Mehta S, Parry A, Durie-Gair J, Nicholson J, Lascelles K, Everett V, Gibbon FM, Jarvis N, Elston J, Evans DG, Halliday D. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population. Arch Dis Child. 2018;103:463–9.

Article  PubMed  Google Scholar 

Gugel I, Grimm F, Teuber C, Zipfel I, Tatagiba M, Mautner VF, Schuhmann MU, Kluwe L. Presenting symptoms I children with neurofibromatosis type 2. Childs Nerv Syst. 2020;36:2463–70.

Article  PubMed  PubMed Central  Google Scholar 

Holmes GL, Stafstrom CE, Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 2007;48:617–30.

Article  PubMed  Google Scholar 

Sujansky E, Conradi S. Outcomes of Sturge-Weber syndrome in 52 adults. Am J Med Genet. 1995;57:35–45.

Article  CAS  PubMed  Google Scholar 

Koo AB, Yeung J, Freedman IG, Lee JH, Ahmed OM, Ma AK, Miyagishima DF, DiLuna M, Kahle K. Clinical and economic burden of neurofibromatosis type 2 in the United States. Clin Neurol Neurosurg. 2020;197:106053.

Article  PubMed  Google Scholar 

Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG. Predictors of the risk of mortality in neurofiblomatosis 2. Am J Hum Genet. 2002;71:715–23.

Article  PubMed  PubMed Central  Google Scholar 

Aboukais R, Zairi F, Baroncini M, Bonne NX, Schapira S, Vincent C, Lejeune JP. Causes of mortality in neurofiblomatosis type 2. Br J Neurosurg. 2015;29:37–40.

Article  PubMed  Google Scholar 

Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52:450–61.

Article  CAS  PubMed  Google Scholar 

Hexter A, Jones A, Joe H, Heap L, Smith MJ, Wallace AJ, Halliday D, Parry A, Taylor A, Raymond L, Shaw A, Afridi S, Obholzer R, Axon P, King AT, English Specialist NF2 Research Group, Friedman JM, Evans DG. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients. J Med Genet. 2015;52:699–705.

Article  CAS  PubMed  Google Scholar 

Papadodima SA, Athanaselis SA, Skiliros S, Spiliopoulou CA. Forensic investigation of submersion deaths. Int J Clin Pract. 2010;64:75–83.

Article  CAS  PubMed  Google Scholar 

Schmidt P, Madea B. Homicide in the bathtub. Forensic Sci Int. 1995;72:135–46.

Article  CAS  PubMed  Google Scholar 

Schmidt P, Madea B. Death in the bathtub involving children. Forensic Sci Int. 1995;72:147–55.

Article  CAS  PubMed  Google Scholar 

Cihan E, Hesdorffer DC, Brandsoy M, Li L, Fowler DR, Graham JK, Donner EJ, Devinsky O, Friedman D. Dead in the water: epilepsy-related drowning or sudden unexpected death in epilepsy? Epilepsia. 2018;59:1966–72.

Article  CAS  PubMed  Google Scholar 

Hayashi K, Jin K, Nagamori C, Okanari K, Okanishi T, Homma Y, Imura Y, Uda T, Takada L, Otsubo H. Sudden unexpected death in epilepsy in the bathtub. Epilepsy Behav. 2019;96:33–40.

Article  PubMed  Google Scholar 

Sexena A, Ang LC. Epilepsy and bathtub drowning. Importance neuropathological pbservations. Am J Forensic Med Pathol. 1993;14:125–9.

Article  Google Scholar 

Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. An upadate on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol. 2020;139:643–65.

Article  PubMed  Google Scholar 

Ruggieri M, Prtico AD, Serra A, Maiolino L, Cocuzza S, Di Mauro P, Ruggieri M, Praticò AD, Serra A, Maiolino L, Cocuzza S, Di Mauro P, Licciardello L, Milone P, Privitera G, Belfiore G, Di Pietro M, Di Raimondo F, Romano A, Chiarenza A, Muglia M, Polizzi A, Evans DG, et al. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital. 2016;36:345–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG. The location of constitutional neurofiblomatosis 2 (NF2) splice site mutations is associated with severity of NF2. J Med Genet. 2005;42:540–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baser ME, Friedmann JM, Joe H, Shenton A, Wallace AJ, Ramsden RT, Evans DG. Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genet Med. 2011;13:576–81.

Article  CAS  PubMed  Google Scholar 

Baser ME, Makariou EV, Parry DM. Predictors of vestibular shwannoma growth in patient with neurofiblomatosis type 2. J Neurosurg. 2002;96:217–22.

Article  PubMed  Google Scholar 

Perry A, Kurtkaya-Yapicier O, Scheithauer BW, Robinson S, Prayson RA, Kleinschmidt-DeMasters BK, Stemmer-Rachamimov AO, Gutmann DH. Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature. Brain Pathol. 2005;15:55–65.

Article  PubMed  Google Scholar 

Kashlan ON, LaBorde DV, Davison L, Saindane AM, Brat D, Hudgins PA, Gross RE. Meningioangiomatosis: a case report and literature review emphasizing diverse appearance on different imaging modalities. Case Rep Neurol Med. 2011;2011:361203.

PubMed  PubMed Central  Google Scholar 

Omeis I, Hillard VH, Braun A, Benzil DL, Murali R, Harter DH. Meningioangiomatosis associated with neurofibromatosis: report of 2 cases in a single family and review of the literature. Surg Neurol. 2006;65:595–603.

Article  PubMed  Google Scholar 

Tomkinson C, Lu JQ, Meningioangiomatosis. A review of the variable manifestations and complex pathophysiology. J Neuro Sci. 2018;392:130–6.

Article  PubMed  Google Scholar 

Rubinstein LJ. The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropahological study of 22 cases. Ann N Y Acad Sci. 1986;486:14–29.

Article  CAS  PubMed  Google Scholar 

Jeon TY, Kim JH, Suh YL, Ahn S, Yoo Sy, Eo H. Sporadic meningioangiomatosis: imaging findings with histopathologic correlations in seven patients. Neuroradiology. 2013;55:1439–46.

Article  PubMed  Google Scholar 

Fedi M, Kalnins RM, Shuey N, Fitt GJ, Newton M, Mitchell LA. Cystic meningioangiomatosis in neurofibromatosis type2: an MRI-pathological study. Br J Radiol. 2009;82:e129–32.

Article  CAS